Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Brandt, John T, Triplett, Douglas A, Alving, Barbara, Scharrer, Inge·1995·Thrombosis and Haemostasis
DOI 10.1055/s-0038-1649901

Cited by (993)

Items 101–200 of 993

  1. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus
    Male, Christoph, Foulon, Denise, Hoogendoorn, Hugh, Vegh, Patricia, Silverman, Earl, David, Michèle, Mitchell, Lesley · 2005 · Blood
  2. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome
    Hui Shi, Hui Wen Zheng, Yufeng Yin, Qiongyi Hu, Jialin Teng, Yue Sun, Hong-Lei Liu, Xiaobing Cheng, Junna Ye, Yutong Su et al. · 2017 · Clinical Chemistry and Laboratory Medicine (CCLM)
  3. Cryoglobulinemia in systemic lupus erythematosus: Prevalence and clinical characteristics in a series of 122 patients
    Mario García‐Carrasco, Manuel Ramos‐Casals, Ricard Cervera · 2001 · Seminars in Arthritis and Rheumatism
  4. Coagulation assays and anticoagulant monitoring
    Dorothy M. Adcock Funk · 2012 · Hematology
  5. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus
    Lúcia Maria Arruda Campos, M. H. B. Kiss, Élbio Antônio D’Amico · 2003 · Lupus
  6. Predictors of maternal and fetal complications in SLE patients: a prospective study
    Elisabetta Borella, Andrea Lojacono, Mariele Gatto, Laura Andréoli, Marco Taglietti, Luca Iaccarino, Edoardo Casiglia, Leonardo Punzi, Anǵela Tincani, Andrea Doria · 2014 · Immunologic Research
  7. Usefulness of PFA‐100® testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time
    Gian Marco Podda, Paolo Bucciarelli, Federico Lussana · 2007 · Journal of Thrombosis and Haemostasis
  8. Cognitive impairment and employment status in systemic lupus erythematosus: A prospective longitudinal study
    Simone Appenzeller, Fernando Cendes, Lílian Tereza Lavras Costallat · 2009 · Arthritis Care & Research
  9. The expanding spectrum of renal diseases associated with antiphospholipid syndrome
    Fádi Fakhouri, Laure‐Hélène Noël, Julien Zuber, H Beaufils, Frank Martinez, Pierre Lebon, T. Papo, Dominique Chauveau, O Blétry, Jean‐Pierre Grünfeld et al. · 2003 · American Journal of Kidney Diseases
  10. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins
    Armando Tripodi, Veena Chantarangkul, Marigrazia Clerici · 2001 · British Journal of Haematology
  11. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile
    Pengo, V., Ruffatti, A., Del Ross, T., Tonello, M., Cuffaro, S., Hoxha, A., Banzato, A., Bison, E., Denas, G., Bracco, A. et al. · 2013 · Journal of Thrombosis and Haemostasis
  12. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants
    Megan O. Nakashima, Heesun Joyce Rogers · 2014 · Blood Research
  13. Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34Leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss
    Astrid Dossenbach‐Glaninger, Michael van Trotsenburg, Martin R.K Dossenbach, Christian Oberkanins, Anne Moritz, Walter Krugluger, Johannes C. Huber, P. Hopmeier · 2003 · Clinical Chemistry
  14. The risk of recurrent venous thromboembolism among patients with high factor IX levels
    A. Weltermann, Sabine Eichinger, Christine Bialonczyk, Erich Minar, Mirko Hirschl, Peter Quehenberger, Verena Schönauer, Paul Alexander Kyrle · 2003 · Journal of Thrombosis and Haemostasis
  15. Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q10 treatment
    C. Pérez‐Sánchez, Patricia Ruiz‐Limón, Maria Angeles Aguirre, María Laura Bertolaccini, Munther A. Khamashta, Antonio Rodríguez‐Ariza, P. Segui, Eduardo Collantes‐Estévez, Nuria Barbarroja, Husam M. Khraiwesh et al. · 2012 · Blood
  16. Acute psychosis in systemic lupus erythematosus
    Simone Appenzeller, Fernando Cendes, Lílian Tereza Lavras Costallat · 2007 · Rheumatology International
  17. Antiphospholipid antibody testing and standardization
    Devreese, K. M. J. · 2014 · International Journal of Laboratory Hematology
  18. Association of antiphospholipid antibodies with retinalvascular disease in systemic lupus erythematosus
    Alfredo Montehermoso, Ricard Cervera, Josep Font · 1999 · Seminars in Arthritis and Rheumatism
  19. Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
    M J Cuadrado, Paula Buendía, Francisco Velasco, Maria Angeles Aguirre, Nuria Barbarroja, L.A. TORRES, Munther A. Khamashta, Chary López-Pedrera · 2006 · Journal of Thrombosis and Haemostasis
  20. Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study
    Jean‐Christophe Gris, Thomas Perneger, Isabelle Quéré, Éric Mercier, Pascale Fabbro-Péray, Géraldine Lavigne-Lissalde, Médéric Hoffet, Hervé Déchaud, Jean-Christophe Boyer, Sylvie Ripart-Neveu et al. · 2003 · Blood
  21. Antihistone and anti–double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus
    Josefina Cortés-Hernández, Josep Ordi‐Ros, Moisés Labrador‐Horrillo, Segundo Buján, Eva Balada, Alfons Segarra-Medrano, Miquel Vilardell · 2004 · The American Journal of Medicine
  22. Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples
    Vittorio Pengo, Alessandra Biasiolo, Paolo Gresele, Francesco Marongiu, Nicoletta Erba, Fabio Veschi, Angelo Ghirarduzzi, Erica De Candia, Barbara Montaruli, Sophie Testa et al. · 2007 · Journal of Thrombosis and Haemostasis
  23. Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus
    Mariana Postal, Aline Tamires Lapa, Nailú Angélica Sinicato, Karina de Oliveira Peliçari, Fernando Augusto Peres, Lílian Tereza Lavras Costallat, Paula Teixeira Fernandes, Roberto Marini, Simone Appenzeller · 2016 · Journal of Neuroinflammation
  24. Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants
    Devreese, Katrien, Peerlinck, Kathelijne, Hoylaerts, Marc F. · 2010 · Blood
  25. High titer of anti–phosphatidylserine‐prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa
    Tamihiro Kawakami, Masahide Yamazaki, Masako Mizoguchi, Yoshinao Soma · 2007 · Arthritis Care & Research
  26. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long-term, followup study
    Félix Pérez‐Villa, Josep Font, Manel Azqueta · 2005 · Arthritis & Rheumatism
  27. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome
    Chary López-Pedrera, Patricia Ruiz‐Limón, Maria Angeles Aguirre, Nuria Barbarroja, C. Pérez‐Sánchez, Paula Buendía, Inés C. Rodríguez-García, Antonio Rodríguez‐Ariza, Eduardo Collantes‐Estévez, Francisco Velasco et al. · 2010 · Annals of the Rheumatic Diseases
  28. Renal Involvement in Primary Antiphospholipid Syndrome
    Renato Alberto Sinico, Ilaria Cavazzana, Monica Nuzzo, Monica Vianelli, Pietro Napodano, Patrizia Scaini, Anǵela Tincani · 2010 · Clinical Journal of the American Society of Nephrology
  29. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
    María José Cuadrado, María Laura Bertolaccini, Paul Townsend Seed, Maria G. Tektonidou, A. Aguirre, Luisa Micó, Caroline Gordon, Guillermo Ruiz‐Irastorza, Maria-Victoria Egurbide, A. Gil et al. · 2013 · Rheumatology
  30. Impaired Fibrinolysis in the Antiphospholipid Syndrome
    Katie A. Krone, Kristi L. Allen, Keith R. McCrae · 2010 · Current Rheumatology Reports
  31. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies
    Ricardo R Forastiero, Marta Elba Martinuzzo, Gabriela Fernanda De Larrañaga · 2005 · Lupus
  32. High Prevalence of Antiphosphatidylinositol Antibodies in Young Patients With Cerebral Ischemia of Undetermined Cause
    Vincenzo Toschi, Adele Motta, Carlo Castelli, Maria Luisa Paracchini, David Zerbi, Andrea Gibelli · 1998 · Stroke
  33. Review : Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance
    M. Navarro, Ricard Cervera, Josep Font · 1997 · Lupus
  34. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura
    C. Pierrot-Deseilligny Despujol, Marc Michel, Mehdi Khellaf, M Gouault, Liliane Intrator, Philippe Bierling, Bertrand Godeau · 2008 · British Journal of Haematology
  35. Prothrombotic Disorders in Children With Moyamoya Syndrome
    Mariana M. Bonduel, Mirta Hepner, Gabriela B. Sciuccati · 2001 · Stroke
  36. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies
    Eric HACHULLA, U Michon-Pasturel, Didier Leys, Jean‐Pierre Pruvo, Viviane Queyrel, Eric Masy, J Arvieux, Claudine Caron, Françoise Brevet, PY Hatron et al. · 1998 · Lupus
  37. Neuropsychological development of children born to patients with systemic lupus erythematosus
    Francesca Neri, L Chimini, Federica Bonomi, Elena Filippini, Mario Motta, Daniella Forman Faden, Andrea Lojacono, Chiara Biasini Rebaioli, Micol Frassi, Elisabetta Danieli et al. · 2004 · Lupus
  38. Anti‐thyroid Antibodies and Antiphospholipid Syndrome: Evidence of Reduced Fecundity and of Poor Pregnancy Outcome in Recurrent Spontaneous Aborters
    Caterina De Carolis, Elisabetta Greco, Maria Domenica Guarino, Carlo Perricone, Alessandro Dal Lago, Roberto Giacomelli, Luigi Fontana, Roberto Perricone · 2004 · American Journal of Reproductive Immunology
  39. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome
    GALLI, M., REBER, G., DE MOERLOOSE, P., DE GROOT, P.G. · 2008 · Journal of Thrombosis and Haemostasis
  40. The presence of IgG antibodies against β2‐glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant
    C. Rintelen, Rainer Vormittag, Thomas Sailer, Stephan Lehr, Peter Quehenberger, Helmut Rumpold, Christoph Male, Ingrid Pabinger · 2005 · Journal of Thrombosis and Haemostasis
  41. The endogenous thrombin potential and the risk of venous thromboembolism
    Armando Tripodi, Ida Martinelli, Veena Chantarangkul, Tullia Battaglioli, Marigrazia Clerici, Pier Mannuccio Mannucci · 2007 · Thrombosis Research
  42. Anti‐prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15‐year longitudinal study
    Nicola Bizzaro, A. Ghirardello, Sandra Zampieri, Luca Iaccarino, Renato Tozzoli, Amelia Ruffatti, Danilo Villalta, Elio Tonutti, Andrea Doria · 2007 · Journal of Thrombosis and Haemostasis
  43. Challenges in the Diagnosis of the Antiphospholipid Syndrome
    Katrien M.J. Devreese, Marc Hoylaerts · 2010 · Clinical Chemistry
  44. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis
    Lisbeth Aranbicia Aguila, Michelle Remião Ugolini Lopes, Flavia Zon Pretti · 2014 · Clinical Rheumatology
  45. Laboratory Testing for Lupus Anticoagulants: A Review of Issues Affecting Results
    Tripodi, Armando · 2007 · Clinical Chemistry
  46. Anticardiolipin Antibodies in Patients with Chronic Hepatitis C Virus Infection: Characterization in Relation to Antiphospholipid Syndrome
    Josep Ordi‐Ros, J. S. Castro Villarreal, F Monegal · 2000 · Clinical and Diagnostic Laboratory Immunology
  47. Antiphospholipid antibody syndrome
    Wendy Lim · 2009 · Hematology
  48. Antiphospholipid Antibodies
    Douglas A. Triplett · 2002 · Archives of Pathology & Laboratory Medicine
  49. Which are the Best Biological Markers of the Antiphospholipid Syndrome?
    Luis O. Carreras, Ricardo R Forastiero, Marta Elba Martinuzzo · 2000 · Journal of Autoimmunity
  50. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome
    Devreese, Katrien, Hoylaerts, Marc F. · 2009 · European Journal Of Haematology
  51. Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism
    Paolo Bucciarelli, Serena M. Passamonti, Eugenia Biguzzi · 2012 · Journal of Thrombosis and Haemostasis
  52. Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism
    Vinod A. Pullarkat, Mark Ngo, Syma Iqbal · 2002 · British Journal of Haematology
  53. Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: A systematic review and meta-analysis
    Guillaume Moulis, Alexandra Audemard‐Verger, Laurent Arnaud, Cécile Luxembourger, François Montastruc, Amelia Maria Găman, Elisabet Svenungsson, Marco Ruggeri, Matthieu Mahévas, Mathieu Gerfaud‐Valentin et al. · 2015 · Autoimmunity Reviews
  54. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients
    Massimo Cugno, Mara Cabibbe, Monica Galli · 2003 · Blood
  55. A simple method to discriminate between β2-glycoprotein I- and prothrombin-dependent lupus anticoagulants
    Marleen J. A. Simmelink, Ronald H. W. M. Derksen, Jozef Arnout, Philip G. de Groot · 2003 · Journal of Thrombosis and Haemostasis
  56. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus
    Martinez-Berriotxoa, Agustin, Ruiz-Irastorza, Guillermo, Egurbide, Maria-Victoria, Garmendia, Maider, Gabriel Erdozain, Jose, Villar, Irama, Aguirre, Ciriaco · 2007 · Lupus
  57. Thrombosis in systemic lupus erythematosus: Congenital and acquired risk factors
    Antonella Afeltra, Marta Vadacca, Laura Conti · 2005 · Arthritis & Rheumatism
  58. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time
    Gregor Hron, Sabine Eichinger, A. Weltermann, Peter Quehenberger, W. M. Halbmayer, Paul Alexander Kyrle · 2006 · Journal of Thrombosis and Haemostasis
  59. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus
    Christoph Male, Lesley Gayle Mitchell, James A. Julian · 2001 · Blood
  60. Real world experience with antiphospholipid antibody tests: how stable are results over time?
    Erkan, D, Derksen, W J M, Kaplan, V, Sammaritano, L, Pierangeli, S S, Roubey, R, Lockshin, M D · 2005 · Annals of the Rheumatic Diseases
  61. Antiphospholipid syndrome: Laboratory testing and diagnostic strategies
    Thomas L. Ortel · 2012 · American Journal of Hematology
  62. High levels of factor VIII and risk of extra-hepatic portal vein obstruction
    Ida Martinelli, Massimo Primignani, Alessio Aghemo · 2009 · Journal of Hepatology
  63. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome
    Rolf T. Urbanus, Ronald H. W. M. Derksen, Philip G. de Groot · 2007 · Blood Reviews
  64. Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis
    Tatsuya Atsumi, Shigeru Furukawa, Olga Amengual · 2005 · Lupus
  65. Superficial thrombophlebitis and risk for recurrent venous thromboembolism
    Verena Schönauer, Paul Alexander Kyrle, Ansgar Weltermann, Erich Minar, Christine Bialonczyk, Mirko Hirschl, Peter Quehenberger, Barbara Schneider, H Partsch, Sabine Eichinger · 2003 · Journal of Vascular Surgery
  66. Features of 847 Childhood‐Onset Systemic Lupus Erythematosus Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter Study
    Roberta C. Gomes, Marco F. Silva, Kátia Tomie Kozu et al. · 2016 · Arthritis Care & Research
  67. Current Insights into the “Antiphospholipid” Syndrome: Clinical, Immunological, and Molecular Aspects
    David A. Kandiah, Andrej Šali, Yonghua Sheng · 1998 · Advances in immunology
  68. Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
    Alberto Banzato, Nicola Pozzi, Roberta Frasson, Vincenzo De Filippis, Amelia Ruffatti, Elisa Bison, Seena Padayattil Jose, Gentian Denas, Vittorio Pengo · 2011 · Thrombosis Research
  69. Antiphospholipid antibodies in acute coronary syndrome
    K. Veres, Gabriella Lakos, A. Kerényi · 2004 · Lupus
  70. Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry
    Lea Weingarz, Jan Schwonberg, Marc Schindewolf, Carola Hecking, Zsuzsanna Wolf, Matthias Erbe, Adele Weber, Edelgard Lindhoff‐Last, Birgit Linnemann · 2013 · British Journal of Haematology
  71. Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII
    D. W. Jones, Michael J Gallimore, Ian J. Mackie · 2000 · British Journal of Haematology
  72. Dimers of β2-Glycoprotein I Mimic thein Vitro Effects of β2-Glycoprotein I-Anti-β2-glycoprotein I Antibody Complexes
    Bianca C.H. Lutters, Joost C.M. Meijers, Ronald H. W. M. Derksen, Jef Arnout, Philip G. de Groot · 2001 · Journal of Biological Chemistry
  73. Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
    Gebhart, Johanna, Posch, Florian, Koder, Silvia, Perkmann, Thomas, Quehenberger, Peter, Zoghlami, Claudia, Ay, Cihan, Pabinger, Ingrid · 2015 · Blood
  74. Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances
    Vandevelde, Arne, Devreese, Katrien M. J. · 2022 · Journal of Clinical Medicine
  75. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods
    Jennings, Ian, Greaves, Mike, Mackie, Ian J., Kitchen, Steve, Woods, Timothy A. L., Preston, F. Eric, on behalf of the UK National External Quality Assessment Scheme for Blood Coagul ation · 2002 · British Journal of Haematology
  76. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients
    Pál Soltész, K. Veres, Gabriella Lakos, Emese Virág Kiss, László Muszbek, G. Szegedi · 2003 · Lupus
  77. EARLY LOSS OF RENAL TRANSPLANTS IN PATIENTS WITH THROMBOPHILIA
    Michael Fischereder, Peter G hring, H. Schneeberger · 1998 · Transplantation
  78. Genetic influences on cervical and lumbar disc degeneration: A magnetic resonance imaging study in twins
    Philip N. Sambrook, Alex J. MacGregor, Tim D. Spector · 1999 · Arthritis & Rheumatism
  79. Many faces of lupus anticoagulants
    D. A. Triplett · 1998 · Lupus
  80. Antiphospholipid antibody tests: spreading the net
    María Laura Bertolaccini, S Gomez, J F P Pareja, A. Theodoridou, Giovanni Sanna, Graham R.V. Hughes, Munther A. Khamashta · 2005 · Annals of the Rheumatic Diseases
  81. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies
    Wenche Jy, Maike P. Tiede, Carlos Bidot, Lawrence L. Horstman, Joaquin Juan Jimenez, Julio A. Chirinos, Yeon Soong Ahn · 2007 · Thrombosis Research
  82. Influence of age at disease onset in the outcome of paediatric systemic lupus erythematosus
    Élodie Descloux, I. Durieu, Pierre Cochat, Denis Vital-Durand, J. Ninet, Nicole Fabien, Rolando Cimaz · 2009 · Rheumatology
  83. A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulants
    Vittorio Pengo, A. Biasiolo, Cinzia Pegoraro, Sabino Iliceto · 2004 · Journal of Thrombosis and Haemostasis
  84. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis
    Jonathan D Rees, S Lança, P V Marques, José Alfredo Gómez-Puerta, R Moco, C Oliveri, Munther A. Khamashta, G R V Hughes, David P. D’Cruz · 2005 · Annals of the Rheumatic Diseases
  85. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis
    Tamihiro Kawakami · 2010 · The Journal of Dermatology
  86. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults
    Nataša Toplak, Tanja Kveder, Alenka Trampuš-Bakija · 2008 · Autoimmunity Reviews
  87. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study
    Simone Appenzeller, Danilo Rodrigues Pereira, L T Lavras Costallat · 2008 · Lupus
  88. Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients
    Mark Andrew Crowther, D. J. Cook, Lauren E. Griffith · 2004 · Intensive Care Medicine
  89. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus
    Guillermo Ruiz‐Irastorza, M-V Egurbide, Agustín Martínez-Berriotxoa, Jesús María Ugalde, C Aguirre · 2004 · Lupus
  90. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies
    Élodie Descloux, I. Durieu, Pierre Cochat, D. Vital Durand, J. Ninet, Nicole Fabien, Rolando Cimaz · 2007 · Rheumatology
  91. Different Types of Antiphospholipid Antibodies in AIDS
    Gabriela Fernanda De Larrañaga, Ricardo R Forastiero, Luis O. Carreras · 1999 · Thrombosis Research
  92. Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
    Polona Žigon, Katja Perdan Pirkmajer, Matija Tomšič, Tanja Kveder, Borut Božič, Snežna Sodin Šemrl, Saša Čučnik, Aleš Ambrožič · 2015 · Journal of Immunology Research
  93. Low Plasma Levels of Vitamin B 6 Are Independently Associated With a Heightened Risk of Deep-Vein Thrombosis
    Marco Cattaneo, Rosa Maria Lombardi, Anna Lecchi · 2001 · Circulation
  94. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant
    Sciascia, Savino, Murru, Veronica, Garcia-Fernandez, Cesar, Sanna, Giovanni, Khamashta, Munther, Bertolaccini, Maria Laura · 2013 · Thrombosis and Haemostasis
  95. Does seronegative antiphospholipid syndrome really exist?
    Ricard Cervera, Fabrizio Conti, Andrea Doria, Luca Iaccarino, Guido Valesini · 2011 · Autoimmunity Reviews
  96. Outcome of primary antiphospholipid syndrome in childhood
    Marco Gattorno, Fabio Falcini, Angelo Ravelli, Francesco Zulian, Antonella Buoncompagni, Giorgia Martini, Massimo Resti, Paolo P Picco, Alberto Martini · 2003 · Lupus
  97. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study
    Simone Appenzeller, Li M. Li, Lilian T. L. Costallat · 2005 · Brain
  98. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions
    Catharina Wenzel, Brigitte Stoiser, Gottfried Johannes Locker · 2002 · Critical Care Medicine
  99. Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome
    Alexandru Daniel Vlagea, Antonio Gil, María Cuesta‐Corral, Florencia Arribas, Jesús Diez, Paz Lavilla, Dora Pascual‐Salcedo · 2012 · Clinical and Applied Thrombosis/Hemostasis
  100. Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism
    Ingrid Pabinger, Helga Grafenhofer, Alexandra Kaider, Adriana Ilic, Sabine Eichinger, Peter Quehenberger, Peter Wolf Husslein, Christine Mannhalter, Klaus Lechner · 2001 · Arteriosclerosis Thrombosis and Vascular Biology